Why the study?
Does passive transfer of rotavirus-specific IgG prevent or delay rotavirus infection in pigtailed macaques?
Does passive transfer of rotavirus-specific IgG prevent or delay rotavirus infection in pigtailed macaques?
Passively transferred circulating rotavirus-specific IgG antibodies can suppress or delay viral infection in a non-human primate model, supporting the potential efficacy of parenteral rotavirus vaccines.
Supports parenteral rotavirus vaccine development; hypothesis-generating in a macaque model requiring human trials before adoption.
We evaluated the protective role of passively transferred circulating antibodies in protecting non-human primates against experimental rotavirus infection. Pooled sera with rotavirus-specific IgG titers that were either high (1:10,000), intermediate (1:300), or negative (< 1:25) were infused i.v. into naive pigtailed macaques (ages 3-6 months). Rotavirus-specific IgG could be detected in the sera at 18 h in all animals infused with antibody-containing serum, and fecal IgG titers could be detected only in animals given high-titer pooled sera. When orally challenged with 10(6) fluorescent-forming units of a simian rotavirus strain, YK-1, at 18 h after serum transfer, control animals shed virus starting 1-3 days after challenge and continued to shed virus at high titers for 6-8 days, whereas passively immunized macaques did not shed virus or had delayed shedding at low titers for only a limited time. The observation that passively transferred antibodies can suppress or delay viral infection in rotavirus-challenged pigtailed macaques has important implications for the design and testing of parenteral candidate rotavirus vaccines.
No takes yet. Share an insight, caveat, or question.
Westerman et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: